| Similar Articles |
|---|
 |
The Motley Fool
March 15, 2007
Rich Duprey |
Biolase's Brighter Sales Figures With a firm financial footing in place, even after its shares have risen 50% in the past three months, Biolase could be an addition to your portfolio worth smiling about.   |
The Motley Fool
May 9, 2007
Rich Duprey |
BioLase's Dull Quarter The dental laser maker makes good on its promise of a disappointing quarter, but the future may be bright for investors. |
The Motley Fool
April 17, 2007
Rich Duprey |
BioLase Darkens Smiles The dental laser maker warns that quarterly revenues will be dramatically lower. Investors, take note. |
The Motley Fool
November 8, 2006
Rich Duprey |
BioLase Brightens Smiles: Fool by Numbers The dental laser maker released fiscal third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
July 20, 2004
Rich Duprey |
Lasers Lose Focus Dental-equipment manufacturer Biolase reports flat sales. |
The Motley Fool
January 10, 2006
Rich Duprey |
Biolase Brightens Outlook The aesthetic laser company expects to be cash flow-neutral on flat revenues. Investors cheer. |
BusinessWeek
December 8, 2003
Gene G. Marcial |
More Dentists Are Drilling With Biolase Biolase makes laser dental drills quieter and less painful. The stock was knocked down because of an accounting restatement, but some pros think it is a good buy. |
The Motley Fool
July 30, 2004
J. Graham |
Biolase by the Numbers The dental laser company is trying to shore up investor confidence by declaring a dividend and shaking up management, but their poor numbers, among other problems, keep it from being a good buy for now. |
The Motley Fool
May 25, 2006
Stephen D. Simpson |
Same Old Patterson Even deep drilling can't unearth a discount at this dental and veterinary supply distributor. What's more aggravating is having to pay this multiple for the business. |
The Motley Fool
October 7, 2004
Seth Jayson |
Painless? My Assets Another warning from dental tech firm Biolase Technology sends the stock down. |
The Motley Fool
September 10, 2007
Rich Duprey |
A Strategic Alternative for Candela In an SEC filing, hedge fund Third Point LLC reports its discussions of "strategic alternatives" at laser maker Candela. Some say a sale was discussed. Investors should take notice. |
The Motley Fool
June 22, 2004
Dave Marino-Nachison |
Schein Over Europe On Friday, dental and medical products distributor Henry Schein completed the purchase of a set of European operations with roughly $340 million in sales for the fiscal year ended Sept. 30 |
BusinessWeek
November 29, 2004
Gene G. Marcial |
Will More Dentists Ask For Biolase Drills? A management shakeup and a new product at Biolase Technology have rekindled interest in the stock, which has been in a deep funk. |
The Motley Fool
November 5, 2004
Rich Duprey |
Profit From Management Integrity Laser manufacturer Candela's management avoids taking the easy way out to explain shortfalls. It's a sign of management integrity that will lead to future profits. |
The Motley Fool
March 2, 2005
Dave Marino-Nachison |
Henry Schein Shines On Trouble with partner Chiron's full vaccines hasn't stopped Henry Schein's share rise. |
The Motley Fool
January 3, 2007
Matthew Crews |
Henry Schein Herds Immunity The vaccine distributor hopes a strong 2007 will help revive its earnings. Value investors should put Henry Schein on their watch lists until it presents a greater margin of safety. |
BusinessWeek
April 4, 2005
Gene G. Marcial |
Schein Gets Over The Flu Henry Schein, the top producer of flu vaccines in the U.S., reported notable fourth-quarter earnings despite the mandated stoppage of vaccine production last year. |
